Alteogen Inc.

196170KOSDAQResearch and development

Alteogen Inc. (196170, KOSDAQ) reported KRW 216bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202397-10-4256148Consolidated
20241032561409274Consolidated
2025216107145699454Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
2023-10.1%-3.7%57.7%-2.4%
202424.7%59%67%22.1%
202549.5%67.3%65%31.9%

Revenue moved 123.6% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 19,469bn
Close priceKRW 279,500
Listed shares69,655,133
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)161
Women91 (56.5%)
Average tenure4.1 years
Annual pay, menKRW 235,928,546
Annual pay, womenKRW 82,329,760
Pay ratio, women to men34.9%

Other companies in Research and development

63 listed companies file under this classification. Showing 12.

See the whole Research and development list →